Postavke privatnosti

Scientists at the University of California discover a way to turn white fat cells into beige to fight obesity

Researchers at the University of California, San Francisco have discovered a method of converting white fat cells into beige, which burn calories and maintain body temperature, opening up opportunities for new weight loss drugs.

Scientists at the University of California discover a way to turn white fat cells into beige to fight obesity
Photo by: Domagoj Skledar/ arhiva (vlastita)

Researchers from the University of California, San Francisco, have discovered that ordinary white fat cells, which store calories, can be converted into beige fat cells that burn calories to maintain body temperature.

The discovery in mice could pave the way for developing a new class of weight-loss drugs and explain why clinical trials of similar therapies have been unsuccessful.

Until now, researchers believed that creating beige fat might require starting from stem cells. New research published on July 1 in the Journal of Clinical Investigation has shown that ordinary white fat cells can be converted into beige fat cells simply by restricting the production of a certain protein.

"Many thought this was not feasible," said Brian Feldman, MD, PhD, Walter L. Miller, MD, and distinguished professor of pediatric endocrinology, and the study's senior author. "We have shown not only that this approach works in converting white fat cells to beige, but also that the barrier to achieving this is not as high as we thought."

Microscopic image of ordinary white fat, which is transparent.
Ordinary white fat, which is common and stores calories to maintain the body's energy reserves. Image by Liang Li.

Microscopic image of ordinary white fat, which is transparent, and pockets of beige fat cells, which are beige.
White fat without KLF-15 protein, containing small spots of beige fat cells that burn calories (shown above in beige areas within the black circle). Image by Liang Li.

Fat transformation
Many mammals have three "shades" of fat cells: white, brown, and beige. White fat serves as the body's energy reserves, while brown fat cells burn energy to release heat, helping to maintain body temperature.

Beige fat cells combine these characteristics. They burn energy, and unlike brown fat cells, which grow in clusters, beige fat cells are embedded within white fat deposits.

Humans and many other mammals are born with brown fat deposits that help maintain body temperature after birth. However, while brown fat in human babies disappears within the first year of life, beige fat remains.

Humans can naturally convert white fat cells into beige in response to diet or a cold environment. Scientists have tried to mimic this process by encouraging stem cells to become mature beige fat cells.

But stem cells are rare, and Feldman wanted to find a switch that could be turned on to directly convert white fat cells into beige.

"For most of us, white fat is not rare, and we would be happy to part with some of it," Feldman said.

Mice and humans
Feldman knew from his earlier experiments that a protein called KLF-15 plays a role in the metabolism and function of fat cells.

With postdoctoral researcher Liang Li, PhD, Feldman decided to investigate how the protein works in mice, which retain brown fat throughout their lives. They found that KLF-15 is much less prevalent in white fat cells than in brown or beige fat cells.

When they then bred mice with white fat cells that lacked KLF-15, the mice converted them from white to beige. Not only could fat cells switch from one form to another, but without the protein, the default state appeared to be beige.

Researchers then looked at how KLF-15 exerts this influence. They grew human fat cells and found that the protein controls the amount of a receptor called Adrb1, which helps maintain energy balance.

Scientists knew that stimulating a related receptor, Adrb3, causes weight loss in mice. However, human trials of drugs that act on this receptor have had disappointing results.

Another drug targeting the Adrb1 receptor in humans is more likely to work, according to Feldman, and could have significant advantages over new injectable weight-loss drugs that target appetite and blood sugar.

It could avoid side effects like nausea because its activity would be limited to fat deposits rather than affecting the brain. And the effects would be long-lasting, as fat cells live relatively long.

"We're not there yet, but we're close enough to see how these discoveries could have a major impact on obesity treatment," he said.

Source: University of California

Find accommodation nearby

Creation time: 03 July, 2024

Science & tech desk

Our Science and Technology Editorial Desk was born from a long-standing passion for exploring, interpreting, and bringing complex topics closer to everyday readers. It is written by employees and volunteers who have followed the development of science and technological innovation for decades, from laboratory discoveries to solutions that change daily life. Although we write in the plural, every article is authored by a real person with extensive editorial and journalistic experience, and deep respect for facts and verifiable information.

Our editorial team bases its work on the belief that science is strongest when it is accessible to everyone. That is why we strive for clarity, precision, and readability, without oversimplifying in a way that would compromise the quality of the content. We often spend hours studying research papers, technical documents, and expert sources in order to present each topic in a way that will interest rather than burden the reader. In every article, we aim to connect scientific insights with real life, showing how ideas from research centres, universities, and technology labs shape the world around us.

Our long experience in journalism allows us to recognize what is truly important for the reader, whether it is progress in artificial intelligence, medical breakthroughs, energy solutions, space missions, or devices that enter our everyday lives before we even imagine their possibilities. Our view of technology is not purely technical; we are also interested in the human stories behind major advances – researchers who spend years completing projects, engineers who turn ideas into functional systems, and visionaries who push the boundaries of what is possible.

A strong sense of responsibility guides our work as well. We want readers to trust the information we provide, so we verify sources, compare data, and avoid rushing to publish when something is not fully clear. Trust is built more slowly than news is written, but we believe that only such journalism has lasting value.

To us, technology is more than devices, and science is more than theory. These are fields that drive progress, shape society, and create new opportunities for everyone who wants to understand how the world works today and where it is heading tomorrow. That is why we approach every topic with seriousness but also with curiosity, because curiosity opens the door to the best stories.

Our mission is to bring readers closer to a world that is changing faster than ever before, with the conviction that quality journalism can be a bridge between experts, innovators, and all those who want to understand what happens behind the headlines. In this we see our true task: to transform the complex into the understandable, the distant into the familiar, and the unknown into the inspiring.

NOTE FOR OUR READERS
Karlobag.eu provides news, analyses and information on global events and topics of interest to readers worldwide. All published information is for informational purposes only.
We emphasize that we are not experts in scientific, medical, financial or legal fields. Therefore, before making any decisions based on the information from our portal, we recommend that you consult with qualified experts.
Karlobag.eu may contain links to external third-party sites, including affiliate links and sponsored content. If you purchase a product or service through these links, we may earn a commission. We have no control over the content or policies of these sites and assume no responsibility for their accuracy, availability or any transactions conducted through them.
If we publish information about events or ticket sales, please note that we do not sell tickets either directly or via intermediaries. Our portal solely informs readers about events and purchasing opportunities through external sales platforms. We connect readers with partners offering ticket sales services, but do not guarantee their availability, prices or purchase conditions. All ticket information is obtained from third parties and may be subject to change without prior notice. We recommend that you thoroughly check the sales conditions with the selected partner before any purchase, as the Karlobag.eu portal does not assume responsibility for transactions or ticket sale conditions.
All information on our portal is subject to change without prior notice. By using this portal, you agree to read the content at your own risk.